BioInteractions Ltd is a research and development company specialising in biomaterial technologies for the worldwide medical device industry.

BioInteractions

Med-Tech Innovation Expo is a trade show and exhibition focusing on the medical device manufacturing sector, bringing together professionals from the industry.

Med-Tech Innovation Expo

BioInteractions Ltd | 887 followers on LinkedIn. BioInteractions Ltd. is a leader in innovating multi-action high-performance, biocompatible material technologies.  | BioInteractions is one of the leading companies in providing highly biocompatable materials for medical devices and is an innovative provider of biocompatible solutions to the worldwide medical device and pharmaceutical industry.

Our goal is to contribute positively to improved patient well-being and speedier recovery times through the development and supply of leading edge biomaterials that deliver the best in biocompatibility, haemocompatibility, minimised human-host response, protection against infection, enhanced lubricity and customised drug release.

With over 30 years experience working in the medical device and pharmaceutical industry, BioInteractions is strategically placed to deliver the next generation of biocompatible solutions.

Experienced Healthcare Professional | Expert in Healthcare Product Development and Commercialisation

Sajinder Luthra

Dilli Ghimire

Director at Palm PC World Pvt. Ltd

Suraj Bhandari

Quality Assurance at BioInteractions Ltd

Nan Kirkwood

BioInteractions Ltd

Live from COMPAMED 2024! The BioInteractions team is at 📍 Hall 8b / Stand N20 to discuss how our Surface Active Therapeutics can enhance device performance, improve patient safety, and provide therapeutic benefits. In Germany this week? Drop by Messe Düsseldorf and say hello to our team to learn how we can support your coating needs. Not visiting this year? Click here to learn more about our pioneering Active Surface Therapeutic solutions: https://lnkd.in/eyJk2hP8 #BioInteractions #COMPAMED2024 #MedTech #MedicalDevice #DeviceCoatings #BiocompatibleCoatings

It’s Day 1 at COMPAMED 2024! We're thrilled to announce the launch of AstutePlus®, our latest Surface Active Therapeutic coating for medical devices! AstutePlus® is an advanced antithrombogenic coating designed to prevent fibrin sheath and thrombus formation in blood-contacting devices like central venous catheters (CVCs). This breakthrough solution addresses a major challenge for physicians, enhancing both the safety and effectiveness of treatments like hemodialysis. 📍 Stop by Hall 8b / Stand N20 to learn more about AstutePlus® and our other Active Surface Therapeutic solutions. Our team is here to discuss how BioInteractions can support your coating needs and improve patient outcomes. See you there! #BioInteractions #COMPAMED2024 #MedTech #MedicalDevice #DeviceCoatings #BiocompatibleCoatings

COMPAMED 2024 is just around the corner, and BioInteractions is excited to be a part of this incredible event! Taking place in Düsseldorf from November 11-14, COMPAMED is the premier international trade fair for the medical technology supplier sector, where innovation and the future of healthcare solutions come together. Our team at BioInteractions will be showcasing our pioneering Surface Active Therapeutic solutions that enhance device performance and patient safety while providing therapeutic benefits. Visit us at 📍Hall 8b / Stand N20 to explore our leading edge coating solutions, connect with our team, and learn how we can support your coating needs. See you there! #BioInteractions #COMPAMED2024 #MedTech #MedicalDevice #DeviceCoatings #BiocompatibleCoatings

Ensuring coating efficacy and biocompatibility is crucial for medical devices to meet regulatory standards and remain safe and durable for patient use. At BioInteractions, our Product Pathway Partnership supports manufacturers in navigating complex regulatory environments and optimizing coating procedures for devices with intricate geometries. Discover why leading medical device manufacturers trust our integrated approach: https://lnkd.in/dp9dsZjp #BioInteractions #Medtech #Pharmanews #PPP #RegulatorySupport #DeviceCoating

Healthcare is evolving, and so is the way we protect medical devices from harmful pathogens. The demand for infection-resistant implantable devices is growing, and TridAnt® by BioInteractions is paving the way with its range of Surface Active Therapeutics. Our groundbreaking polymeric matrix delivers fast, full-spectrum pathogen protection, including the ability to disrupt and prevent biofilms—a key requirement in device-related infections. TridAnt® ensures both active and passive antimicrobial defense, safeguarding everything from soft silicones to hard metals, for the entire lifetime of the device. Designed specifically for critical Class 3 implants, our technology enhances patient outcomes by drastically reducing infections and extending device longevity. With TridAnt®, we’re redefining the future of medical device safety. Click here to learn more about our TridAnt® technology: https://lnkd.in/ezXytH3q . #BioInteractions #TridAnt #SurfaceActiveTherapeutics #MedicalDeviceSafety #AntimicrobialCoating #BiofilmPrevention

Arjun Luthra , commercial director of BioInteractions Ltd , shares how Surface Active Therapeutics represent a leap in safeguarding medical devices. https://lnkd.in/eReTPznv #coatings #medicalplastics #implants

Medical Plastics News

BioInteractions’ range of Surface Active Therapeutics create a continuous protective shield on medical devices, preventing infections, thrombosis, and other complications. Our advanced polymer matrix technology ensures sustained protection and therapeutic benefits, improving device efficacy and patient safety. Explore Biointeractions' range of Surface Active Therapeutics today: https://lnkd.in/g497MG7J . #BioInteractions #MedicalDevice #DeviceCoatings #BiocompatibleCoatings #PatientSafety

Surgically implanted devices like total artificial hearts (TAHs), ventricular assist devices (VADs), and vascular stents are critical in supporting vital organs. Yet, they often face the challenge of thrombosis, leading to frequent replacements or lifelong drug regimens. At BioInteractions, we’ve developed Astute®Plus, a state-of-the-art Surface Active Therapeutic coating designed to provide superior biocompatibility and lifetime protection against thrombosis. By mimicking the natural endothelial layer, Astute®Plus prevents fibrin sheath formation and thrombus formation, all while ensuring consistent performance for the device’s lifetime. Our innovative coating is helping improve patient outcomes, reducing the need for device replacements, and lowering dependency on drug therapies. Learn more: https://lnkd.in/gzvMDUCT . #BioInteractions #Astute #Antithrombogenic #SurfaceActiveTherapeutics #Hemocompatibility #MedicalDevices #ThrombosisPrevention

Infection prevention is at the forefront of modern healthcare as the number of healthcare-associated infections (HCAIs) continues to rise. Traditional solutions are not enough to combat the increasing complexity of medical devices and the risk of infections they carry. With Surface Active Therapeutics, antimicrobial technologies like TridAnt® can now provide continuous protection against a broad spectrum of pathogens, including bacteria, viruses, spores and even biofilms. These innovative coatings form a durable, fast-acting protective shield over complex surfaces like catheters, heart valves, and implants, ensuring patients receive safer, more effective treatments for the entire lifetime of their devices. At BioInteractions, we are proud to be at the forefront of this technology, helping shape the future of infection prevention in healthcare. Click here to learn more about our TridAnt® technology: https://lnkd.in/ezXytH3q . #BioInteractions #TridAnt #SurfaceActiveTherapeutics #MedicalDeviceSafety #AntimicrobialCoating #BiofilmPrevention

The BioInteractions Product Pathway Partnership (PPP) provides access to a complete all-in-one coating partner to support your growth and development. The PPP service is a result of over 30 years of experience combined with our state of the art materials and customer focused services to streamline the development and regulatory process for new innovations. For more information, click here: https://lnkd.in/dp9dsZjp . #BioInteractions #Medtech #Pharmanews #PPP #RegulatorySupport #DeviceCoating

Metric
Company Name	BioInteractions	Med-Tech Innovation Expo
Symbol
MSH ID	COM:BIOINTERACTIONS	COM:MED-TECHEXPO
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Biotechnology	Medical Device Manufacturing
Country	GB	GB
Stage
Employee Count
Website	biointeractions.com	med-techexpo.com
LinkedIn	biointeractions-ltd	med-tech-innovation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIOI

COM:BIOINTERACTIONS

BioInteractions

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue